Consolidated Portfolio Review Corp’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-2,016
Closed -$316K – 96
2025
Q3
$316K Buy
+2,016
New +$311K 0.04% 360

Other funds holding CAH

Consolidated Portfolio Review Corp's CAH Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Cardinal Health (CAH) in Q4 2025, closing a stake of 2,016 shares — an estimated $316K sold.

Consolidated Portfolio Review Corp first reported a position in CAH in Q3 2025 and held it in 1 quarter. The position peaked at $316K in Q3 2025. 1,412 funds tracked by Wall St. Rank hold CAH as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining Cardinal Health position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 2,016 Cardinal Health shares in Q4 2025, an estimated $316K.
  • Consolidated Portfolio Review Corp first reported a position in Cardinal Health in Q3 2025 and held it in 1 quarter.
  • Consolidated Portfolio Review Corp's Cardinal Health position peaked at $316K in Q3 2025.
  • 1,412 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.